Insight into the Mechanism of Interactions between the LL-37 Peptide and Model Membranes of <i>Legionella gormanii</i> Bacteria.
Pastuszak. Katarzyna K; Kowalczyk. Bozena B; Tarasiuk. Jacek J; Luchowski. Rafal R; Gruszecki. Wieslaw I WI; Jurak. Małgorzata M; Palusinska-Szysz. Marta M
Key Findings
- LL-37 kills L. gormanii in a dose‑dependent way and can make the bacteria viable but non‑cultivable at low micromolar levels
- The peptide preferentially binds to negatively charged bacterial membranes because of its positive charge
- LL-37 can insert into the lipid tail region, destabilising the membrane, and its effectiveness is altered by the bacteria’s choline‑derived lipid composition
Practical Outcomes
- The work suggests that membrane lipid makeup influences how well LL‑37 works, hinting that dietary choline or other ways to modify cell membrane composition might affect susceptibility to antimicrobial peptides. However, the findings are from model membranes and do not provide specific dosing or protocols for human use.
Summary
The study shows that the natural antimicrobial peptide LL‑37 can stick to and break down the outer membrane of the pneumonia‑causing bacterium Legionella gormanii, especially when the membrane is negatively charged. Its ability to disrupt the membrane depends on how the bacteria’s lipids are arranged, which changes if the bacteria use extra choline. This is a lab‑based, mechanistic finding, not a direct human treatment guide.
Abstract
<i>Legionella gormanii</i> is a fastidious, Gram-negative bacterium known to be the etiological agent of atypical community-acquired pneumonia. The human cathelicidin LL-37 exhibits a dose-dependent bactericidal effect on <i>L. gormanii</i>. The LL-37 peptide at the concentration of 10 µM causes the bacteria to become viable but not cultured. The antibacterial activity of the peptide is attributed to its effective binding to the bacterial membrane, as demonstrated by the fluorescence lifetime imaging microscopy. In this study, to mimic the <i>L. gormanii</i> membranes and their response to the antimicrobial peptide, Langmuir monolayers were used with the addition of the LL-37 peptide to the subphase of the Langmuir trough to represent the extracellular fluid. The properties of the model membranes (Langmuir monolayers) formed by phospholipids (PL) isolated from the <i>L. gormanii</i> bacteria cultured on the non-supplemented (PL-choline) and choline-supplemented (PL+choline) medium were determined, along with the effect of the LL-37 peptide on the intermolecular interactions, packing, and ordering under the monolayer compression. Penetration tests at the constant surface pressure were carried out to investigate the mechanism of the LL-37 peptide action on the model membranes. The peptide binds to the anionic bacterial membranes preferentially, due to its positive charge. Upon binding, the LL-37 peptide can penetrate into the hydrophobic tails of phospholipids, destabilizing membrane integrity. The above process can entail membrane disruption and ultimately cell death. The ability to evoke such a great membrane destabilization is dependent on the share of electrostatic, hydrogen bonding and Lifshitz-van der Waals LL-37-PL interactions. Thus, the LL-37 peptide action depends on the changes in the lipid membrane composition caused by the utilization of exogenous choline by the <i>L. gormanii</i>.
Study Information
pubmed
2023
2023-07-27T00:00:00.000Z
10.3390/ijms241512039
8
41